Role of BRI2 in dementia

Journal of Alzheimer's Disease

Volumn 40, Issue 3, 2014, Pages 481-494

  Del Campo, Marta ^a,b   Teunissen, Charlotte E ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; amyloid ; amyloid protein precursor; familial British dementia (FBD); familial Danish dementia (FDD); integral membrane protein 2B (ITM2B BRI2)

Indexed keywords

AMYLOID PROTEIN; INSULINASE; INTEGRAL MEMBRANE PROTEIN 2B; MEMBRANE PROTEIN; PRESENILIN 1; PROTEIN; UNCLASSIFIED DRUG; ITM2B PROTEIN, HUMAN;

ALZHEIMER DISEASE; AMNESIA; DEMENTIA; GENE MUTATION; HUMAN; NEUROFIBRILLARY TANGLE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; VASCULAR AMYLOIDOSIS; ANIMAL; BIOLOGICAL MODEL; BRAIN; GENETIC PREDISPOSITION; GENETICS; METABOLISM; MUTATION;

ANIMALS; BRAIN; DEMENTIA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MEMBRANE GLYCOPROTEINS; MODELS, BIOLOGICAL; MUTATION;

EID: 84901943174     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131364     Document Type: Review

References (128)

1. Vidal R, Frangione B, Rostagno A, Mead S, R'ev'esz T, Plant G, Ghiso J (1999) A stop-codon mutation in the BRI gene associated with familial British dementia. Nature 399, 776- 781. (Pubitemid 29293172)
2. Vidal R, Revesz T, Rostagno A, Kim E, Holton JL, Bek T, Bojsen-Møller M, Braendgaard H, Plant G, Ghiso J, Frangione B (2000) A decamer duplication in the 3' region of the BRI gene originates an amyloid peptide that is associated with dementia in a Danish kindred. Proc Natl Acad Sci U S A 97, 4920-4925. (Pubitemid 30238658)
3. Garringer HJ, Murrell J, D'Adamio L, Ghetti B, Vidal R (2010) Modeling familial British and Danish dementia. Brain Struct Funct 214, 235-244.
4. Rostagno A, Tomidokoro Y, Lashley T, Ng D, Plant G, Holton J, Frangione B, Revesz T, Ghiso J (2005) Chromosome 13 dementias. Cell Mol Life Sci 62, 1814-1825. (Pubitemid 41188521)
5. Tsachaki M, Ghiso J, Efthimiopoulos S (2008) BRI2 as a central protein involved in neurodegeneration. Biotechnol J 3, 1548-1554.
6. Fotinopoulou A, Tsachaki M, Vlavaki M, Poulopoulos A, Rostagno A, Frangione B, Ghiso J, Efthimiopoulos S (2005) BRI2 interacts with amyloid precursor protein (APP) and regulates amyloid beta (Abeta) production. J Biol Chem 280, 30768-30772. (Pubitemid 41291806)
7. Matsuda S, Giliberto L, Matsuda Y, Davies P, McGowan E, Pickford F, Ghiso J, Frangione B, D'Adamio L (2005) The familial dementia BRI2 gene binds the Alzheimer gene amyloid-beta precursor protein and inhibits amyloid-beta production. J Biol Chem 280, 28912-28916. (Pubitemid 41161336)
8. Kim J, Miller VM, Levites Y, West KJ, Zwizinski CW, Moore BD, Troendle FJ, Bann M, Verbeeck C, Price RW, Smithson L, Sonoda L, Wagg K, Rangachari V, Zou F, Younkin SG, Graff-Radford N, Dickson D, Rosenberry T, Golde TE (2008) BRI2 (ITM2b) inhibits Abeta deposition in vivo. J Neurosci 28, 6030-6036.
9. Peng S, Fitzen M, J?ornvall H, Johansson J (2010) The extracellular domain of Bri2 (ITM2B) binds the ABri peptide (1-23) and amyloid beta-peptide (Abeta1-40): Implications for Bri2 effects on processing of amyloid precursor protein and Abeta aggregation. Biochem Biophys Res Commun 393, 356-361.
10. Pittois K, Deleersnijder W, Merregaert J (1998) cDNA sequence analysis, chromosomal assignment and expression pattern of the gene coding for integral membrane protein 2B. Gene 217, 141-149. (Pubitemid 28427316)
11. Deleersnijder W, Hong G, Cortvrindt R, Poirier C, Tylzanowski P, Pittois K, Marck E,Van, Merregaert J (1996) Isolation of markers for chondro-osteogenic differentiation using cDNA library subtraction. J Biol Chem 271, 19475- 19482.
12. Vidal R, Calero M, R'ev'esz T, Plant G, Ghiso J, Frangione B (2001) Sequence, genomic structure and tissue expression of human BRI3, a member of the BRI gene family. Gene 266, 95-102. (Pubitemid 32268660)
13. Hedlund J, Johansson J, Persson B (2009) BRICHOS - a superfamily of multidomain proteins with diverse functions. BMC Res Note 2, 180.
14. Willander H, Hermansson E, Johansson J, Presto J (2011) BRICHOS domain associated with lung fibrosis, dementia and cancer-a chaperone that prevents amyloid fibril formation? FEBS J 278, 3893-3904.
15. S'anchez-Pulido L, Devos D, Valencia A (2002) BRICHOS: A conserved domain in proteins associated with dementia, respiratory distress and cancer. Trends Biochem Sci 27, 329- 332. (Pubitemid 34756511)
16. Willander H, Presto J, Askarieh G, Biverst°al H, Frohm B, Knight SD, Johansson J, Linse S (2012) BRICHOS domains efficiently delay fibrillation of amyloid -peptide. J Biol Chem 287, 31608-31617.
17. Tsachaki M, Serlidaki D, Fetani A, Zarkou V, Rozani I, Ghiso J, Efthimiopoulos S (2011) Glycosylation of BRI2 on asparagine 170 is involved in its trafficking to the cell surface but not in its processing by furin or ADAM10. Glycobiology 21, 1382-1388.
18. Vidal R, Delisle MB, Ghetti B (2004) Neurodegeneration caused by proteins with an aberrant carboxyl-terminus. J Neuropathol Exp Neurol 63, 787-800. (Pubitemid 39038501)
19. Tsachaki M, Ghiso J, Rostagno A, Efthimiopoulos S (2010) BRI2 homodimerizes with the involvement of intermolecular disulfide bonds. Neurobiol Aging 31, 88-98.
20. Choi S, Vidal R, Frangione B, Levy E, Alzheimer I (2003) Axonal transport of British and Danish amyloid peptides via secretory vesicles. FASEB J 18, 373-375.
21. Pickford F, Onstead L, Camacho-Prihar C, Hardy J, McGowanE(2003) Expression ofmBRI2 in mice. Neurosci Lett 338, 95-98.
22. Akiyama H, Kondo H, Arai T, Ikeda K, Kato M, Iseki E, Schwab C, McGeer PL (2004) Expression of BRI, the normal precursor of the amyloid protein of familial British dementia, in human brain. Acta Neuropathol 107, 53-58. (Pubitemid 38088275)
23. Lashley T, Revesz T, Plant G, Bandopadhyay R, Lees A, Frangione B, Wood N, de Silva R, Ghiso J, Rostagno A, Holton J (2008) Expression of BRI2 mRNA and protein in normal human brain and familial British dementia: Its relevance to the pathogenesis of disease. Neuropathol Appl Neurobiol 34, 492-505.
24. Matsuda S, Tamayev R, D'Adamio L (2011) Increased APP processing in familial Danish dementia patients. J Alzheimers Dis 27, 385-391.
25. Martin L, Fluhrer R, Haass C (2009) Substrate requirements for SPPL2b-dependent regulated intramembrane proteolysis. J Biol Chem 284, 5662-5670.
26. Martin L, Fluhrer R, Reiss K, Kremmer E, Saftig P, Haass C (2008) Regulated intramembrane proteolysis of Bri2 (Itm2b) by ADAM10 and SPPL2a/SPPL2b. J Biol Chem 283, 1644-1652.
27. Kim SH, Wang R, Gordon DJ, Bass J, Steiner DF, Lynn DG, Thinakaran G, Meredith SC, Sisodia SS (1999) Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia. Nat Neurosci 2, 984-988. (Pubitemid 30599561)
28. Matsuda S, MatsudaY, Snapp EL, D'Adamio L (2009) Maturation of BRI2 generates a specific inhibitor that reduces APP processing at the plasma membrane and in endocytic vesicles. Neurobiol Aging 32, 1400-1408.
29. Nakayama K (1997) Furin: A mammalian subtilisin/Kex2plike endoprotease involved in processing of a wide variety of precursor proteins. Biochem J 327, 625-635. (Pubitemid 27487665)
30. Molloy SS, Anderson ED, Jean F, Thomas G (1999) Bi-cycling the furin pathway: From TGN localization to pathogen activation and embryogenesis. Trends Cell Biol 9, 28-35. (Pubitemid 29138669)
31. Kim S-H, Creemers JWM, Chu S, Thinakaran G, Sisodia SS (2002) Proteolytic processing of familial British dementiaassociated BRI variants: Evidence for enhanced intracellular accumulation of amyloidogenic peptides. J Biol Chem 277, 1872-1877. (Pubitemid 34968761)
32. Fleischer A, Ayll'on V, Dumoutier L, Renauld J-C, Rebollo A (2002) Proapoptotic activity of ITM2B(s), a BH3-only protein induced upon IL-2-deprivation which interacts with Bcl-2. Oncogene 21, 3181-3189. (Pubitemid 34548088)
33. Selkoe D, Kopan R (2003) Notch and Presenilin: Regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci 26, 565-597. (Pubitemid 37064944)
34. Fleischer A, Ayllon V, Rebollo A (2002) ITM2BS regulates apoptosis by inducing loss of mitochondrial membrane potential. Eur J Immunol 32, 3498-3505. (Pubitemid 36032654)
35. Fleischer A, RebolloA(2004) Induction of p53-independent apoptosis by the BH3-only protein ITM2Bs. FEBS Lett 557, 283-287. (Pubitemid 38115910)
36. Latil A, Cĥene L, Mangin P, Fournier G, Berthon P, Cussenot O (2003) Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion. Prostate 57, 39-50. (Pubitemid 37070148)
37. Han C, Park I, Lee B, Jin S, Choi H, Kwon JT, Kwon Y, Kim DH, Park ZY, Cho C (2011) Identification of heat shock protein 5, calnexin and integral membrane protein 2B as Adam7-interacting membrane proteins in mouse sperm. J Cell Physiol 226, 1186-1195.
38. Matsuda S, Giliberto L, Matsuda Y, McGowan EM, D'AdamioL(2008) BRI2 inhibits amyloid beta-peptide precursor protein processing by interfering with the docking of secretases to the substrate. J Neurosci 28, 8668-8676.
39. Blennow K, de Leon MJ, Zetterberg H (2006) Alzheimer's disease. Lancet 368, 387-403. (Pubitemid 44108123)
40. Ramon y Cajal S (1929) Degeneration and regeneration of the nervous system. J Neurol Psychopathol 9, 378.
41. Shankar GM, Walsh DM (2009) Alzheimer's disease: Synaptic dysfunction and Abeta. Mol Neurodegener 4, 48.
42. Grundke-Iqbal I, Iqbal K, Tung YC, Quinlan M, Wisniewski HM, Binder LI (1986) Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology. Proc Natl Acad Sci U S A 83, 4913- 4917.
43. Masters CL, Simms G,WeinmanNA,Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 82, 4245-4249. (Pubitemid 15053619)
44. Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
45. Walsh DM, Selkoe DJ (2007) A beta oligomers - a decade of discovery. J Neurochem 101, 1172-1184.
46. Lesn'e SE, Sherman MA, Grant M, Kuskowski M, Schneider JA, Bennett DA, Ashe KH (2013) Brain amyloid- oligomers in ageing and Alzheimer's disease. Brain 136, 1383-1398.
47. Zahs KR, Ashe KH (2013) -Amyloid oligomers in aging and Alzheimer's disease. Front Aging Neurosci 5, 28.
48. Chow VW, Mattson MP, Wong PC, Gleichmann M (2009) An overview of APP processing enzymes and products. Neuromolecular Med 12, 1-12.
49. Cai H, Wang Y, McCarthy D, Wen H, Borchelt DR, Price DL, Wong PC (2001) BACE1 is the major beta-secretase for generation of Abeta peptides by neurons. Nat Neurosci 4, 233-234. (Pubitemid 32194867)
50. Luo Y, Bolon B, Kahn S, Bennett BD, Babu-khan S, Denis P, Fan W, Kha H, Zhang J, Gong Y, Martin L, Louis J, Yan Q, Richards WG, Citron M, Vassar R (2001) Mice deficient in BACE1, the Alzheimer's -secretase, have normal phenotype and abolished -amyloid generation. Nat Neurosci 4, 231-232. (Pubitemid 32194866)
51. Passer B, Pellegrini L, Russo C, Siegel RM, Lenardo MJ, Schettini G, Bachmann M, Tabaton M, Adamio LD (2000) Generation of an apoptotic intracellular peptide by -secretase cleavage of Alzheimer's amyloid protein precursor. J Alzheimers Dis 2, 289-301. (Pubitemid 32095613)
52. Strooper B, De (2003) Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-secretase complex. Neuron 38, 9-12. (Pubitemid 36423348)
53. O'Brien R, Wong P (2011) Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci 34, 185-204.
54. Endres K, Fahrenholz F (2012) Regulation of alphasecretase ADAM10 expression and activity. Exp Brain Res 217, 343-352.
55. Kuhn P-H, Wang H, Dislich B, Colombo A, Zeitschel U, Ellwart JW, Kremmer E, Rossner S, Lichtenthaler SF (2010) ADAM10 is the physiologically relevant, constitutive alpha-secretase of the amyloid precursor protein in primary neurons. EMBO J 29, 3020-3032.
56. Lammich S, Kojro E, Postina R, Gilbert S, Pfeiffer R, Jasionowski M, Haass C, Fahrenholz F (1999) Constitutive and regulated -secretase cleavage of Alzheimer's amyloid precursor protein by a disintegrin metalloprotease. Proc Natl Acad Sci U S A 96, 3922-3927. (Pubitemid 29169012)
57. Hardy J, Allsop D (1991) Amyloid deposition as the central event in the aetiology of Alzheimer's disease. Trends Pharmacol Sci 12, 383-388.
58. Haass C, Selkoe DJ (2007) Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer's amyloid beta-peptide. Nat Rev Mol Cell Biol 8, 101-112. (Pubitemid 46432529)
59. Hardy J, Selkoe DJ (2002) The amyloid hypothesis of Alzheimer's disease: Progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
60. Karran E, Mercken M, De Strooper B (2011) The amyloid cascade hypothesis for Alzheimer's disease: An appraisal for the development of therapeutics. Nat Rev Drug Discov 10, 698-712.
61. Tomita T, Maruyama K, Saido TC, Kume H, Shinozaki K, Tokuhiro S, Capell A, Walter J, Gr?unberg J, Haass C, Iwatsubo T, Obata K (1997) The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue. Proc Natl Acad Sci U S A 94, 2025-2030. (Pubitemid 27113955)
62. Citron M,WestawayD, XiaW, Carlson G, DiehlT, Levesque G, Johnson-Wood K, Lee M, Seubert P, Davis A, Kholodenko D, Motter R, Sherrington R, Perry B, Yao H, Strome R, Lieberburg I, Rommens J, Kim S, Schenk D, Fraser P, St George Hyslop P, Selkoe DJ (1997) Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med 3, 67-72. (Pubitemid 27019143)
63. Citron M, Oltersdorf T, Haass C, McConlogue L, Hung AY, Seubert P, Vigo-Pelfrey C, Lieberburg I, Selkoe DJ (1992) Mutation of the beta-amyloid precursor protein in familial Alzheimer's disease increases beta-protein production. Nature 360, 672-674. (Pubitemid 23007680)
64. Hsiao K, Chapman P, Nilsen S, Eckman C, Harigaya Y, Younkin S, Yang F, Cole G (1996) Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science 274, 99-102. (Pubitemid 26332733)
65. Chishti MA, Yang D, Janus C, Phinney AL, Horne P, Pearson J, Strome R, Zuker N, Loukides J, French J, Turner S, Lozza G, Grilli M, Kunicki S, Paquette J, Gervais F, Bergeron C, Fraser PE, Carlson GA, George-hyslop PS, George-hyslop S (2001) Early-onset amyloid deposition and cognitive deficits in transgenic mice expressing a double mutant form of amyloid precursor protein 695. J Biol Chem 276, 21562-21570. (Pubitemid 37413154)
66. Davies L, Wolska B, Hilbich C, Multhaup G, Martins R, Simms G, Beyreuther K, Masters CL (1988) A4 amyloid protein deposition and the diagnosis of Alzheimer's disease: Prevalence in aged brains determined by immunocytochemistry compared with conventional neuropathologic techniques. Neurology 38, 1688-1693. (Pubitemid 18265030)
67. Schmitt FA, Davis DG, Wekstein DR, Smith CD, Ashford JW, Markesbery WR (2000) "Preclinical" AD revisited: Neuropathology of cognitively normal older adults. Neurology 55, 370-376. (Pubitemid 30654797)
68. Morgan K (2011) The three new pathways leading to Alzheimer's disease. Neuropathol Appl Neurobiol 37, 353- 357.
69. Boada M, Ant'unez C, Ram'irez-Lorca R, Destefano AL, Gonz'alez-P'erez A, Gay'an J, L'opez-Arrieta J, Ikram MA, Hern'andez I, Mar'in J, Gal'an JJ, Bis JC, Maule'on A, Rosende-Roca M, Moreno-Rey C, Gudnasson V, Mor'on FJ, Velasco J, Carrasco JM, Alegret M, Espinosa A, Vinyes G, Lafuente A, Vargas L, Fitzpatrick AL; for the Alzheimer's Disease Neuroimaging Initiative, Launer LJ, S'aez ME, V'azquez E, Becker JT, L'opez OL, Serrano-R'ios M, T'arraga L, van Duijn CM, Real LM, Seshadri S, Ruiz A (2013) ATP5H/KCTD2 locus is associated with Alzheimer's disease risk. Mol Psychiatry, doi: 10.1038/mp.2013.86.
70. Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JSK, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T,Williams J, Lambert J-C, Amouyel P, Goate A, Rademakers R, Morgan K, Powell J, St George-Hyslop P, Singleton A, Hardy J (2013) TREM2 variants in Alzheimer's disease. N Engl J Med 368, 117-127.
71. Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson PV, Snaedal J, Bjornsson S, Huttenlocher J, Levey AI, Lah JJ, Rujescu D, Hampel H, Giegling I, Andreassen OA, Engedal K, Ulstein I, Djurovic S, Ibrahim-Verbaas C, Hofman A, Ikram MA, van Duijn CM, Thorsteinsdottir U,Kong A, Stefansson K (2012) Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med 368, 107-116.
72. Neumann H, Daly MJ (2012) Variant TREM2 as risk factor for Alzheimer's disease. N Engl J Med 368, 182-184.
73. Lee H, Zhu X, Castellani RJ, Nunomura A, Perry G, Smith MA (2007) Amyloid- in Alzheimer disease: The null versus the alternate hypotheses. J Pharmacol Exp Ther 321, 823-829. (Pubitemid 46762675)
74. Plant GT, R'ev'esz T, Barnard RO, Harding AE, Gautier- Smith PC (1990) Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation. Brain 113, 721-747. (Pubitemid 20222328)
75. Mead S, James-Galton M, Revesz T, Doshi RB, Harwood G, Pan EL, Ghiso J, Frangione B, Plant G (2000) Familial British dementia with amyloid angiopathy: Early clinical, neuropsychological and imaging findings. Brain 123, 975- 991. (Pubitemid 30224193)
76. Holton JL, Lashley T, Ghiso J, Braendgaard H, Vidal R, Guerin CJ, Gibb G, Hanger DP, Rostagno A, Anderton BH, Strand C,Ayling H, Plant G, Frangione B, Bojsen-Møller M, Revesz T (2002) Familial Danish dementia: A novel form of cerebral amyloidosis associated with deposition of both amyloid-Dan and amyloid-beta. J Neuropathol Exp Neurol 61, 254-267. (Pubitemid 34212600)
77. Holton JL, Ghiso J, Lashley T, Rostagno A, Guerin CJ, Gibb G, Houlden H, Ayling H, Martinian L, Anderton BH, Wood NW, Vidal R, Plant G, Frangione B, Revesz T (2001) Regional distribution of amyloid-Bri deposition and its association with neurofibrillary degeneration in familial British dementia. Am J Pathol 158, 515-526. (Pubitemid 32158612)
78. Rostagno A, Revesz T, Lashley T, Tomidokoro Y, Magnotti L, Braendgaard H, Plant G, Bojsen-Møller M, Holton J, Frangione B, Ghiso J (2002) Complement activation in chromosome 13 dementias. Similarities with Alzheimer's disease. J Biol Chem 277, 49782-49790. (Pubitemid 36014425)
79. Lashley T, Holton JL, Verbeek MM, Rostagno A, Bojsen- Møller M, David G, van Horssen J, Braendgaard H, Plant G, Frangione B, Ghiso J, Revesz T (2006) Molecular chaperons, amyloid and preamyloid lesions in the BRI2 gene-related dementias: A morphological study. Neuropathol Appl Neurobiol 32, 492-504. (Pubitemid 44401511)
80. Schwab C, Arai T, Hasegawa M, Akiyama H, Yu S, McGeer PL (2009) TDP-43 pathology in familial British dementia. Acta Neuropathol 118, 303-311.
81. Lashley T, Holton JL, Revesz T (2011) TDP-43 pathology may occur in the BRI2 gene-related dementias. Acta Neuropathol 121, 559-560.
82. Seubert P, Vigo-Pelfrey C, Esch F, Lee M, Dovey H, Davis D, Sinha S, Schlossmacher M, Whaley J, Swindlehurst C (1992) Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature 359, 325-327.
83. Ghiso JA, Holton J, Miravalle L, Calero M, Lashley T, Vidal R, Houlden H, Wood N, Neubert TA, Rostagno A, Plant G, Revesz T, Frangione B (2001) Systemic amyloid deposits in familial British dementia. J Biol Chem 276, 43909-43914.
84. TomidokoroY, LashleyT, Rostagno A, NeubertT, a, Bojsen- Møller M, Braendgaard H, Plant G, Holton J, Frangione B, R'ev'esz T, Ghiso J (2005) Familial Danish dementia: Coexistence of Danish and Alzheimer amyloid subunits (ADan ANDAbeta) in the absence of compact plaques. J Biol Chem 280, 36883-36894.
85. Holton JL, Ghiso J, Lashley T, Ganguly M, Strand K, Rostagno A, Plant G, Frangione B, Revesz T (2002) Familial British dementia (FBD): A cerebral amyloidosis with systemic amyloid deposition. Neuropathol Appl Neurobiol 28, 148-148.
86. El-Agnaf OM, Nagala S, Patel BP, Austen BM (2001) Nonfibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils. J Mol Biol 310, 157-168. (Pubitemid 32619959)
87. Gibson G, Gunasekera N, Lee M, LelyveldV, El-Agnaf OM, Wright A, Austen B (2003) Oligomerization and neurotoxicity of the amyloid ADan peptide implicated in familial Danish dementia. J Neurochem 88, 281-290.
88. TomidokoroY, Lashley T, Rostagno A, Neubert TA, Bojsen- Møller M, Braendgaard H, Plant G, Holton J, Frangione B, R'ev'esz T, Ghiso J (2005) Familial Danish dementia: Coexistence of Danish and Alzheimer amyloid subunits (ADan ANDAbeta) in the absence of compact plaques. J Biol Chem 280, 36883-36894. (Pubitemid 41587770)
89. Mori H, Takio K, Ogawara M, Selkoe DJ (1992) Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. J Biol Chem 267, 17082-17086.
90. Saul A, Lashley T, Revesz T, Holton J, Ghiso JA, Coomaraswamy J, Wirths O (2013) Abundant pyroglutamate-modified ABri and ADan peptides in extracellular and vascular amyloid deposits in familial British and Danish dementias. Neurobiol Aging 34, 1416-1425.
91. Go?ni F, Prelli F, Ji Y, Scholtzova H, Yang J, Sun Y, Liang F-X, Kascsak R, Kascsak R, Mehta P,Wisniewski T (2010) Immunomodulation targeting abnormal protein conformation reduces pathology in a mouse model of Alzheimer's disease. PLoS One 5, e13391.
92. Pickford F, Coomaraswamy J, Jucker M, McGowan E (2006) Modeling familial British dementia in transgenic mice. Brain Pathol 16, 80-85.
93. Vidal R, BarbeitoAG,Miravalle L, GhettiB(2009) Cerebral amyloid angiopathy and parenchymal amyloid deposition in transgenic mice expressing the Danish mutant form of human BRI2. Brain Pathol 19, 58-68.
94. Garringer HJ, Murrell J, Sammeta N, Gnezda A, Ghetti B, Vidal R (2013) Increased tau phosphorylation and tau truncation, and decreased synaptophysin levels in mutant BRI2/tau transgenic mice. PLoS One 8, e56426.
95. P'erez M, Mor'an MA, Ferrer I, Avila J, G'omez-Ramos P (2008) Phosphorylated tau in neuritic plaques of APP(sw)/Tau (vlw) transgenic mice and Alzheimer disease. Acta Neuropathol 116, 409-418.
96. Coomaraswamy J, Kilger E, W?olfing H, Sch?afer C, Kaeser S, a, Wegenast-Braun BM, Hefendehl JK, Wolburg H, Mazzella M, Ghiso J, Goedert M, Akiyama H, Garcia-Sierra F, Wolfer DP, Mathews PM, Jucker M (2010) Modeling familial Danish dementia in mice supports the concept of the amyloid hypothesis of Alzheimer's disease. Proc Natl Acad Sci U S A 107, 7969-7974.
97. Saura C, a, Choi S-Y, Beglopoulos V, Malkani S, Zhang D, Shankaranarayana Rao BS, Chattarji S,Kelleher RJ, Kandel ER, Duff K, Kirkwood A, Shen J (2004) Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-dependent neurodegeneration. Neuron 42, 23-36. (Pubitemid 38456965)
98. Giliberto L, Matsuda S, Vidal R, D'Adamio L (2009) Generation and initial characterization of FDD knock in mice. PLoS One 4, e7900.
99. Tamayev R, Giliberto L, Li W, D'Abramo C, Arancio O, Vidal R, D'AdamioL(2010) Memory deficits due to familial British dementia BRI2 mutation are caused by loss of BRI2 function rather than amyloidosis. J Neurosci 30, 14915- 14924.
100. Tamayev R, Matsuda S, F'a M, Arancio O, Adamio LD (2010) Danish dementia mice suggest that loss of function and not the amyloid cascade causes synaptic plasticity and memory deficits. Proc Natl Acad Sci U S A 107, 20822- 20827.
101. Harris VK, Diamanduros A, Good P, Zakin E, Chalivendra V, Sadiq SA (2010) Bri2-23 is a potential cerebrospinal fluid biomarker in multiple sclerosis. Neurobiol Dis 40, 331-339.
102. Tamayev R, Matsuda S, Giliberto L, Arancio O, D'Adamio L (2011) APP heterozygosity averts memory deficit in knockin mice expressing the Danish dementia BRI2 mutant. EMBO J 30, 2501-2509.
103. Kilger E, Buehler A, Woelfing H, Kumar S, Kaeser SA, Nagarathinam A, Walter J, Jucker M, Coomaraswamy J (2011) BRI2 regulates beta-amyloid degradation by increasing levels of secreted insulin degrading enzyme (IDE). J Biol Chem 286, 37446-37457.
104. Tamayev R, Matsuda S, Arancio O, D'Adamio L (2012) - but not -secretase proteolysis of APP causes synaptic and memory deficits in a mouse model of dementia. EMBO Mol Med 4, 171-179.
105. Tamayev R, D'Adamio L (2012) Memory deficits of British Dementia knock-in mice are prevented by APP haploinsufficiency. J Neurosci 32, 5481-5485.
106. Tamayev R, D'Adamio L (2012) Inhibition of -secretase worsens memory deficits in a genetically congruous mouse model of Danish dementia. Mol Neurodegener 7, 19.
107. Melnikova T, Fromholt S, Kim H, Lee D, Xu G, Price A, Moore BD, Golde TE, Felsenstein KM, Savonenko A, Borchelt DR (2013) Reversible pathologic and cognitive phenotypes in an inducible model of Alzheimeramyloidosis. J Neurosci 33, 3765-3779.
108. Kim J, Chakrabarty P, Hanna A, March A, Dickson DW, Borchelt DR, Golde T, Janus C (2013) Normal cognition in transgenic BRI2-A mice. Mol Neurodegener 8, 15.
109. Tsachaki M, Fotinopoulou A, Slavi N, Zarkou V, Ghiso J, Efthimiopoulos S (2013) BRI2 interacts with BACE1 and regulates its cellular levels by promoting its degradation and reducing its mRNA levels. Curr Alzheimer Res 10, 532-541.
110. Zhao J, Fu Y, Yasvoina M, Shao P, Hitt B, O'Connor T, Logan S, Maus E, Citron M, Berry R, Binder L, Vassar R (2007) Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: Implications for Alzheimer's disease pathogenesis. J Neurosci 27, 3639-3649. (Pubitemid 46557686)
111. Zhang X-M, Cai Y, Xiong K, Cai H, Luo X-G, Feng JC, Clough RW, Struble RG, Patrylo PR, Yan X-X (2009) Beta-secretase-1 elevation in transgenic mouse models of Alzheimer's disease is associated with synaptic/axonal pathology and amyloidogenesis: Implications for neuritic plaque development. Eur J Neurosci 30, 2271-2783.
112. Coulson DTR, Beyer N, Quinn JG, Brockbank S, Hellemans J, Irvine GB, Ravid R, Johnston JA (2010) BACE1 mRNA expression in Alzheimer's disease postmortem brain tissue. J Alzheimers Dis 22, 1111-1122.
113. ReitzC(2012) Alzheimer's disease and the amyloid cascade hypothesis: A critical review. Int J Alzheimers Dis 2012, 369808.
114. Lewis J, DicksonDW, Lin WL, Chisholm L, Corral A, Jones G,Yen SH, Sahara N, Skipper L,Yager D, Eckman C, Hardy J, Hutton M, McGowan E (2001) Enhanced neurofibrillary degeneration in transgenic mice expressing mutant tau and APP. Science 293, 1487-1491. (Pubitemid 32801551)
115. G?otz J, Chen F, van Dorpe J, NitschRM(2001) Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils. Science 293, 1491-1495. (Pubitemid 32807681)
116. Gamblin TC, Chen F, Zambrano A, Abraha A, Lagalwar S, Guillozet AL, Lu M, Fu Y, Garcia-Sierra F, LaPointe N, Miller R, Berry RW, Binder LI, Cryns VL (2003) Caspase cleavage of tau: Linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci U S A 100, 10032-10037. (Pubitemid 37087063)
117. Mawuenyega KG, SigurdsonW, Ovod V, Munsell L, Kasten T, Morris JC,Yarasheski KE, Bateman RJ (2011) Decreased clearance of CNS amyloid- in Alzheimer's disease. Science 330, 1174.
118. Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, Love S (2008) Abeta-degrading enzymes in Alzheimer's disease. Brain Pathol 18, 240-252.
119. Qiu WQ, Walsh DM, Ye Z, Vekrellis K, Zhang J, Podlisny MB, Rosner MR, Safavi A, Hersh LB, Selkoe DJ (1998) Insulin-degrading enzyme regulates extracellular levels of amyloid beta-protein by degradation. J Biol Chem 273, 32730-32738. (Pubitemid 28557658)
120. FarrisW, Mansourian S, Chang Y, Lindsley L, Eckman EA, Frosch MP, Eckman CB, Tanzi RE, Selkoe DJ, Guenette S (2003) Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci U S A 100, 4162-4167. (Pubitemid 36418174)
121. Morelli L, Llovera RE, Alonso LG, Frangione B, de Prat- Gay G, Ghiso J, Casta?no EM (2005) Insulin-degrading enzyme degrades amyloid peptides associated with British and Danish familial dementia. Biochem Biophys Res Commun 332, 808-816. (Pubitemid 40745185)
122. Moehlmann T, Winkler E, Xia X, Edbauer D, Murrell J, Capell A, Kaether C, Zheng H, Ghetti B, Haass C, Steiner H (2002) Presenilin-1 mutations of leucine 166 equally affect the generation of the Notch and APP intracellular domains independent of their effect on Abeta 42 production. Proc Natl Acad Sci U S A 99, 8025-8030. (Pubitemid 34650999)
123. Radde R, Bolmont T, Kaeser SA, Coomaraswamy J, Lindau D, Stoltze L, Calhoun ME, J?aggi F, Wolburg H, Gengler S, Haass C, Ghetti B, Czech C, H?olscher C, Mathews PM, Jucker M (2006) Abeta42-driven cerebral amyloidosis in transgenic mice reveals early and robust pathology. EMBO Rep 7, 940-946. (Pubitemid 44523975)
124. Haass C, Lemere CA, Capell A, Citron M, Seubert P, Schenk D, Lannfelt L, Selkoe DJ (1995) The Swedish mutation causes early-onset Alzheimer's disease by -secretase cleavage within the secretory pathway. Nat Med 1, 1291- 1296.
125. Kinoshita A, Fukumoto H, Shah T, Whelan CM, Irizarry MC, Hyman BT (2003) Demonstration by FRET of BACE interaction with the amyloid precursor protein at the cell surface and in early endosomes. J Cell Sci 116, 3339-3346. (Pubitemid 37038982)
126. Jahn H, Wittke S, Z?urbig P, Raedler TJ, Arlt S, Kellmann M, Mullen W, Eichenlaub M, Mischak H, Wiedemann K (2011) Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: Identification and prospective evaluation of new synaptic biomarkers. PLoS One 6, e26540.
127. Selkoe DJ (1991) The molecular of Alzheimer's pathology disease review. Neuron 6, 487-498.
128. Lambert J-C, Heath S, Even G, Campion D, Sleegers K, Hiltunen M, Combarros O, Zelenika D, Bullido MJ, Tavernier B, Letenneur L, Bettens K, Berr C, Pasquier F, Fi'evet N, Barberger-Gateau P, Engelborghs S, De Deyn P, Mateo I, Franck A, Helisalmi S, Porcellini E, Hanon O, de Pancorbo MM, Lendon C, Dufouil C, Jaillard C, Leveillard T, Alvarez V, Bosco P, Mancuso M, Panza F, Nacmias B, Boss'u P, Piccardi P, Annoni G, Seripa D, Galimberti D, Hannequin D, Licastro F, Soininen H, Ritchie K, Blanch'e H, Dartigues JF, Tzourio C, Gut I, Van Broeckhoven C, Alp'erovitch A, Lathrop M, Amouyel P (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease. Nat Genet 41, 1094-1099.